Condition: Type 2 Diabetes · Cortisol Excess · Sponsor: Sparrow Pharmaceuticals
CAPTAIN-T2D will take place in two parts. Part 1 (Screening) will evaluate patients with type 2 diabetes and elevated cortisol risk factors for trial eligibility and the presence of elevated cortisol. Participants deemed eligible from Part 1 will be randomized to either clofutriben or placebo in the double-blind (participant and investigator), dose-ranging, interventional Part 2 (Treatment).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Arizona Clinical Trials - Pecos | Chandler, Arizona, United States | Recruiting |
| Arizona Clinical Trials - Broadway | Tucson, Arizona, United States | Recruiting |
| Ark Clinical Research - Fountain Valley | Fountain Valley, California, United States | Recruiting |
| Velocity Clinical Research, Huntington Park | Huntington Park, California, United States | Recruiting |
| Velocity Clinical Research - Gardena | La Mesa, California, United States | Recruiting |
| Ark Clinical Research - Long Beach | Long Beach, California, United States | Recruiting |
| Los Angeles Institute for Metabolic Research | Los Angeles, California, United States | Recruiting |
| Velocity Clinical Research, Los Angeles | Los Angeles, California, United States | Recruiting |
| Amicis Research Center- Nordhoff | Northridge, California, United States | Recruiting |
| Alliance Clinical San Diego | San Diego, California, United States | Not Yet Recruiting |
| Velocity Clinical Research, New Smyrna Beach | Edgewater, Florida, United States | Recruiting |
| The Center for Diabetes and Endocrine Care | Fort Lauderdale, Florida, United States | Recruiting |
+ 48 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07296484